Safety study of biologics in pregnancy for newborns
Part of Immune system & allergy, Women’s health & pregnancy clinical trials.
This trial looks at whether biologic medicines used during pregnancy are safe for the baby after birth. If your baby was born to a mother taking a biologic for an autoimmune disease, this study may be trying to track and confirm newborn safety outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born to a mother who was taking a biologic medicine during pregnancy
- The biologic was part of treatment for the mother’s autoimmune disease
- You are available for newborn safety monitoring as the study requires
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for biological markers in the mother's blood that might predict how exposure to inflammation during pregnancy could change a baby's brain development. The goal is to understand these effects in healthy pregnancies and those with certain inflammatory conditions.
This study looks at two substances in the blood from the umbilical cord (IL-6 and lactate) to see if they can help doctors understand how well a newborn is doing after birth.
This study looks at how safe certain IBD medications are when taken during pregnancy and while breastfeeding. It follows mothers and their babies to check for any health effects.
This study looks at how monoclonal antibody treatments given during pregnancy affect a baby's immune system development. It compares babies whose mothers received these treatments throughout pregnancy, only in early pregnancy, or not at all.
This study looks at how certain multiple sclerosis medications (monoclonal antibodies) might affect the immune system of children whose mothers took them during pregnancy. It aims to understand if these treatments have any impact on the baby's developing immune system.
This study looks at how pregnancy and newborn outcomes turn out for people with inflammatory bowel disease (IBD) who are pregnant and taking immune-suppressing medicines or biologic therapies. It may help doctors better understand risks and care for mothers and babies in similar situations.
Hear when a new Suspected Damage to Fetus From Biologic Agents trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.